... Read More
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
Washington, June 10 (ANI): A new long-term weight-loss medication called Beliviq, which had been approved by FDA, will be available to patients by next week. The drug, which received FDA approval almost a year ago, makes users feel that they are full by working on serotonin transmitters in the brain, which causes this reaction. CBS News medical contributor Dr Holly Phillips said on CBS This Morning: Saturday that when a person feels full, they eat less, and then they see the weight loss.
She said that Beliviq was considered to be effective, and people taking it lost around 3.7 percent of their body weight over the year, asserting that in studies the drug worked better in non-diabetics than people who already were diagnosed with that disease. She said that the drug is not a miracle cure for obesity, but people have to look at it from a health perspective, where if an obese person loses 5 percent of their body weight it can truly benefit you.
What is obesity?
Obesity is a condition where a person s Body Mass Index or BMI (calculated by dividing height by weight) is more than 30. It is becoming a global epidemic not only in developed nations but also in developing nations like India. Obesity is usually linked to a host of disorders like diabetes, heart diseases, hypertension and strokes. Easy availability of sugars and fats, messing with our body clocks and an increased sedentary lifestyle are responsible for obesity. Being overweight and obesity are the fifth leading risk for global deaths with at least 2.8 million adults dying each year due to them. Also read why quick-fix weight loss products don't work.